Dermarest Psoriasis Medicated

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Dermarest Psoriasis Medicated
Generic name
SALICYLIC ACID
Manufacturer
Insight Pharmaceuticals LLC
Product type
HUMAN OTC DRUG
SPL set ID
c6a64946-bafd-449f-90cc-e2f6201285f3
SPL ID
4d7aaa63-b932-410a-8c20-84364a940c26
Version
5
Effective date
2024-10-25
Source export date
2026-10-12
Source partition
5
Source file
https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/13cbfcd236c665f0ee69e2d9141331148dcdff45d1679c92f029cfba27dd74a2/drug-label-0005-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 01:44:07
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Ask a doctor before use if you have psoriasis that covers a large area of the body When using this product avoid contact with the eyes. If contact occurs, rinse the eyes thoroughly with water. Stop use and ask a doctor if condition worsens or does not improve after regular use as directed Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.